Skip Navigation

Publications

Peer Reviewed

  1. Corey JM, 2006. Genetic disorders producing compressive radiculopathy. Semin Neurol.  Nov;26(5):515-22.

  2. Corey JM, Lin DY, Mycek KB, Chen Q, Samuel S, Feldman EL, Martin DC, 2007. Aligned   electrospun nanofibers specify the direction of dorsal root ganglia neurite growth. J Biomed Mater Res A. 2007 Dec 1;83(3):636-45.

  3. Corey JM, Gertz CC, Wang B-S, Birrell LK, Johnson SL, Martin DC, Feldman EL. The design of  electrospun PLLA nanofiber scaffolds compatible with serum-free growth of primary motor and sensory neurons. Acta Biomater. 2008 Jul;4(4):863-75

  4. Vincent AM, Sakowski SA, Schuyler A, Feldman EL.Strategic approaches to developing drug treatments for ALS.Drug Discov Today. 2008 Jan;13(1-2):67-72.

  5. Vincent AM, Feldman EL.Can drug screening lead to candidate therapies for testing in diabetic neuropathy?Antioxid Redox Signal. 2008 Feb;10(2):387-94.

  6. Sullivan KA, Hayes JM, Wiggin TD, Backus C, Su Oh S, Lentz SI, Brosius F 3rd, Feldman EL.Mouse models of diabetic neuropathy.Neurobiol Dis. 2007 Dec;28(3):276-85.

  7. Vincent AM, Russell JW, Sullivan KA, Backus C, Hayes JM, McLean LL, Feldman EL.SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.Exp Neurol. 2007 Dec;208(2):216-27.

  8. Corey JM, Lin DY, Mycek KB, Chen Q, Samuel S, Feldman EL, Martin DC.Aligned electrospun nanofibers specify the direction of dorsal root ganglia neurite growth.J Biomed Mater Res A. 2007 Dec 1;83(3):636-45.

  9. Heavner SB, Rubin AD, Fung K, Old M, Hogikyan ND, Feldman EL. Dysfunction of the recurrent laryngeal nerve and the potential of gene therapy.Ann Otol Rhinol Laryngol. 116(6):441-8, 2007.

  10. Fung K, Hogikyan ND, Heavner SB, Ekbom D, Feldman EL. Development and characterisation of an experimental recurrent laryngeal nerve injury model for the study of viral gene therapy. J Laryngol Otol. 25:1-6, 2007.

  11. Little AA, Edwards JL, Feldman EL. Diabetic neuropathies. Pract Neurol. 7(2):82-92, 2007.

  12. Vincent AM, Perrone L, Sullivan KA, Backus C, Sastry AM, Lastoskie C, Feldman EL. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology. 148(2):548-58, 2007.

  13. Leinninger GM, Edwards JL, Lipshaw MJ, Feldman EL. Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol. 2(11):620-8, 2006.

  14. van Golen CM, Schwab TS, Kim B, Soules ME, Su Oh S, Fung K, van Golen KL, Feldman EL. Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone. Cancer Research. 1;66(13):6570-8, 2006.

  15. Gruis KL, Brown DL, Weatherwax KJ, Feldman EL, Chervin RD. Evaluation of sham non-invasive ventilation for randomized, controlled trials in ALS. Amyotrophic Lateral Sclerosis. 7(2):96-9, 2006.

  16. Smith AG, Russell J, Feldman EL, Goldstein J, Peltier A, Smith S, Hamwi J, Pollari D, Bixby B, Howard J, Singleton JR. Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care. 29(6):1294-9, 2006.

  17. Leinninger GM, Backus C, Sastry AM, Yi YB, Wang CW, Feldman EL. Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1. Neurobiology of Disease. 23(1):11-22, 2006.

  18. Gruis KL, Brown DL, Lisabeth LD, Zebarah VA, Chervin RD, Feldman EL. Longitudinal assessment of noninvasive positive pressure ventilation adjustments in ALS patients. Journal of Neurological Science. 15;247(1):59-63, 2006.

  19. Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, Stevens MJ, Feldman EL; DCCT/EDIC Research Group. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care. 29(2):340-4, 2006.

  20. Gruis KL, Brown DL, Schoennemann A, Zebarah VA, Feldman EL. Predictors of noninvasive ventilation tolerance in patients with amyotrophic lateral sclerosis. Muscle Nerve. Dec;32(6):808-11, 2005.

  21. Feldman EL. Biomedical research: a culture in crisis? Nature Clinical Practice Neurology, 1, 61, 2005.

  22. Kim B, Feldman EL. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells. Endocrinology, 146, 5350-5357, 2005.

  23. Vincent AM, Stevens MJ, Backus C, McLean LL, Feldman EL. Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury. Antioxidants & Redox Signaling. 7(11-12):1494-506, 2005.

  24. Sullivan KA, Feldman EL. New developments in diabetic neuropathy. Current Opinion in Neurology, 18, 586-590, 2005.

  25. Russo VC, Gluckman P, Feldman EL, Werther GA. The insulin-like growth factor system and its pleiotropic functions in brain. Endocrine Reviews, Aug. 30 doi:10.1210/er.2004-0024, 2005.

  26. Stevens MJ, Larkin DD, Feldman EL, Del Monte MA, Greene DA. Establishment, maintenance, and transfection of in vitro cultures of human retinal pigment epithelium. Methods in Molecular Medicine, 107, 343-351, 2005.

  27. Vincent AM, Backus C, Taubman AA, Feldman EL. Identification of candidate drugs for the treatment of ALS. Amyotrophic Lateral Sclerosis, 6, 29-36, 2005.

  28. Schwab TS, Madison BB, Grauman AR , Feldman EL. Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells. Apoptosis, 10, 831-840, 2005.

  29. Leinninger GM, Feldman EL. Insulin-like growth factors in the treatment of neurological disease. Endocrine Development, 9, 135-159, 2005.

  30. Boulton AJM, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D. Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care, 28, 956-962, 2005.

  31. Kim B, Oh SS, van Golen CM, Feldman EL. Differential regulation of insulin receptor substrate-1 degradation during mannitol and okadaic acid induced apoptosis in human neuroblastoma cells. Cellular Signalling, 17, 769-775, 2005.

  32. Meyer A, van Golen CM, Boyanapalli M, Kim B, Soules ME, Feldman EL. Integrin-linked kinase complexes with caveolin-1 in human neuroblastoma cells. Biochemistry, 44, 932-938, 2005.

  33. Meyer G, Kim B, van Golen CM, Feldman EL. Cofilin activity during insulin-like growth factor I-stimulated neuroblastoma cell motility. Cellular and Molecular Life Sciences, 62, 461-470, 2005.

  34. Vincent AM, McLean LL, Backus C, and Feldman EL. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB Journal 19, 638-640, 2005.

  35. Singleton JR, Smith AG, Russell J, Feldman EL. Polyneuropathy with impaired glucose tolerance (prediabetes): Implications for diagnosis and therapy. Current Treatment Options in Neurology, 7, 33-42, 2005.

  36. Teng Q, Tanase D, Liu J, Garrity-Moses M, Boulis NM. Adenoviral Tetanus Toxin Light Chain Gene-Based Synaptic Inhibition through Neuronal Synaptobrevin Elimination. Gene Therapy 12(2) 108-119, 2005.

  37. Vincent AM, Feldman EL, Song DK, Jung V, Schild A, Zhang W, Imperiale MJ, Boulis NM. Adeno-associated viral-mediated insulin-like growth factor delivery protects motor neurons in vitro.Neuromolecular Med. 6(2-3):79-85, 2004.

  38. Tanase D, Teng Q, Krishnaney AA, Liu JK, Garrity-Moses ME, Mazarakis N, Boulis NM. Cervical spinal cord delivery of a rabies G protein pseudotyped lentiviral vector in the SOD-1 transgenic mouse. J Neurosug (Spine 1)1: 128-136, 2004.

  39. Noordmans AJ, Song DK, Noordmans CJ, During MJ, Fitzsimons H, Imperiale MJ, Boulis NM. Adeno-associated viral glutamate decarboxylase expression in the lateral nucleus of the rat hypothalamus reduces feeding behavior. Gene Therapy 11: 797-804, 2004.

  40. Berent Spillson A, Robinson AM, Golovoy D, Slusher B, Rojas C, Russell JW. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3. J Neurochem, 89:90-99, 2004.

  41. Cowell R, Russell JW. Nitrosative injury and antioxidant therapy in the management of diabetic neuropathy. J Invest Med, 52:33-44, 2004.

  42. Leinninger, GM, Backus, C, Uhler, MD, Lentz SI and Feldman, EL Phosphatidylinositol 3-Kinase and Akt Effectors Mediate Insulin-like Growth Factor-I Neuroprotection in Dorsal Root Ganglia Neurons. FASEB J.18:1544-6, 2004.

  43. Leinninger, GM, Russell, JW, van Golen, CM, Berent, A, and Feldman, EL Insulin-Like Growth Factor-I (IGF-I) Regulates Glucose-Induced Mitochondrial Depolarization and Apoptosis in Human Neuroblastoma.Cell Death and Differentiation, 11(8), 885-896, 2004.

  44. Vincent AM, Olzmann JA, Brownlee M, Sivitz WI , Russell JW. Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes. 53(3):726-34, 2004.

  45. Vega-Warner V, Ransom RF, Vincent AM, Brosius FC, Smoyer WE. Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside. Kidney Int. 66(5):1881-9, 2004.

  46. Rijkers R., Geidda G., van Koningsbruggen S., van Geel M., Lemmers R.J.L.F., van Deutekom J.C.T., Figlewicz D., Hewitt J.E., Padberg G.W., Frants R.R., and van der Maarel S.M. FRG2 , an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. J Medical Genetics 41(11):826-36, 2004.

  47. Slowik A., Borratynska A., Pera J., Betlej M., Dziedzic T., Krzyszkowski T., Czepko R., Figlewicz D.A., and Szczudlik A. II Genotype of the Angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm. Stroke 35: 1594-1597, 2004.

  48. Slowik A., Dziedzic T., Turaj W., Pera J., Glodzik-Sobanska L., Szermer P., Malecki M., Figlewicz D.A., and Szczudlik A. A2 Alelle of GpIIIa gene is a risk factor for stroke caused by large-vessel disease in males. Stroke 35:1589-1593, 2004.

  49. Slowik A., Turaj W., Dziedzic T., Haefele A., Pera J., Malecki M.T., Glodzik-Sobanska L., Szermer P.,Figlewicz D.A., and Szczudlik A. DD genotype of Angiotensin Converting Enzyme gene is a risk factor for spontaneous intracerebral hemorrhage. Neurology 63: 359-361, 2004.

  50. Devlin B., Bennett P., Dawson G., Figlewicz D.A., Grigorenko E.L., McMahon W., Minshew N., Pauls D., Smith M., Spence M.A., Rodier P.M., Stodgell C., The CPEA Genetics Network, and Schellenberg G.D. Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the CPEA network. Am J Medical Genetics 126B: 46-50, 2004.

  51. Leinninger GM, Backus C, Uhler MD, Lentz SI, Feldman EL. Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons. FASEB J, 18, 1544-1546, 2004.

  52. Layton BE, Sastry AM, Lastoskie CM, Philbert MA, Miller TJ, Sullivan KA, Feldman EL, Wang C-W. In situ imaging of mitochondrial outer-membrane pores using atomic force microscopy. BioTechniques, 37, 564-573, 2004.

  53. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocrine Reviews, 25, 612-628, 2004.

  54. Meyer A, van Golen CM, Kim B, van Golen KL, Feldman EL. Integrin expression regulates neuroblastoma attachment and migration. Neoplasia, 6, 332-342, 2004.

  55. Layton BE, Sastry AM, Wang H, Sullivan KA, Feldman EL, Komorowski TE, Philbert MA. Differences between collagen morphologies, properties and distribution in diabetic and normal BioBreeding and Sprague-Dawley rat sciatic nerves, Journal of Biomechanics, 37, 879-888, 2004.

  56. Vincent AM, Mobley BC , Hiller A, Feldman EL. IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiology of Disease, 16, 407-416, 2004.

  57. Leinninger GM, Russell JW, van Golen CM, Berent A, Feldman EL. Insulin-like growth factor-I (IGF-I) regulates glucose-induced mitochondrial depolarization and apoptosis in human neuroblastoma. Cell Death and Differentiation, 11, 885-896, 2004.

  58. Vincent AM, Feldman EL. New insights into the mechanisms of diabetic neuropathy. Reviews in Endocrine & Metabolic Disorders, 5, 227-236, 2004.

  59. Consilvio C, Vincent AM, Feldman EL. Neuroinflammation, COX-2, and ALS – A dual role? Experimental Neurology, 187, 1-10, 2004.

  60. Leinninger GM, Vincent AM,Feldman EL. The role of g rowth f actors in diabetic p eripheral n europathy. Journal of the Peripheral Nervous System, 9, 26-53, 2004.

  61. Kim B, van Golen C, Feldman EL. Insulin-like growth factor-I signaling in human neuroblastoma cells. Oncogene, 23, 130-141, 2004.

Articles Accepted for Publication

  1. Corey JM, Gertz CC, Sutton TJ, Chen Q, Mycek KB, Martin AA, Johnson SL, Feldman EL.  Patterning N-type and S-type Neuroblastoma Cells with Pluronic F108 and ECM Proteins. J Biomed Mater Res A.  In Revision.

  2. Dowling, J.J., E. Gibbs, M. Russell, D. Goldman, J. Minarcik, J.A. Golden, and E.L. Feldman. 2008. Kindlin-2 Is an Essential Component of Intercalated Discs and Is Required for Vertebrate Cardiac Structure and Function. Circ Res. (in press)

  3. Dowling, J.J., Gibbs, E.M., and E.L. Feldmann. 2008. Membrane Traffic and Muscle: Lessons from Human Disease. Traffic (in press)

  4. Vincent AM, Kato K, Soules ME, Feldman EL, Sensory Neurons and Schwann Cells Respond to Oxidative Stress by Increasing Antioxidant Defense Mechanisms, Antiox Redox Signal.

  5. Dowling JJ, Gibbs E, Russell M, Goldman D, Minarcik J, Golden JA, Feldman EL.Kindlin-2 Is an Essential Component of Intercalated Discs and Is Required for Vertebrate Cardiac Structure and Function.Circ Res.

  6. Vincent AM, Edwards JL, Sadidi M, Feldman EL The Antioxidant Response as a Drug Target in Diabetic Neuropathy. Curr Drug Targets.

  7. Sullivan KA, Lentz SI, Roberts JL, Jr., Feldman EL Criteria for Creating and Assessing Mouse Models of Diabetic Neuropathy. Curr Drug Targets.

Chapters in Books

  1. Apoptosis and human diseases:
    Molecular mechanisms: oxidative stress in the pathogenesis of diabetic neuropathy.
    Mahdieh Sadidi, Ann Marie Sastry, Christian M. Lastoskie, Andrea A. Vincent, Kelli A. Sullivan, Eva L. Feldman, Humana Press, Vol 2, p365 , 2007.

  2. Hughes RAC, Feldman E, Bland J. Peripheral nerve disorders. In: Evidence-based Neurology and Neurosurgery, Candelise L, Hughes R, Liberati A, Uitdehaag B, Warlow C, eds., Blackwell Publishing, in press.

  3. Sadidi M, Sastry AM, Lastoskie CM, Vincent AM, Sullivan KA, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. In: Apoptosis and Human Diseases: Molecular Mechanisms. Humana Press, in press.

  4. Russell JW, Cowell RM, Feldman EL. Neuronal and Schwann cell death in diabetic neuropathy. In: Clinical Management of Diabetic Neuropathy, 2 nd ed., Veves A, Malik R, eds., Humana Press, in press.

  5. Singleton JR, Russell JW, Feldman EL. Electrodiagnosis of neuromuscular disease. In: Adult Neurology, Corey-Bloom J, ed., 2 nd ed., Blackwell Publishing, pp. 34-49, 2005.

  6. Steinmetz, MP, Liu, JK, Boulis, NM. Cellular and Gene Therapy Approaches to Spinal Cord Injury. In Molecular Neurosurgery. (Leone and Janson eds) Karger Publishers, Prog Neurolo Surg, in press.

  7. Boulis NM, Rezai AR, Song DK. Thalamotomy. In Therapy of Parkinson’s Disease. Third Edition 2004 (Lyons, Kollers and Pahwa ed), Chap 19; 247-266, 2004.

  8. Kopell B and Boulis NM. Setting Up a Movement Disorder Surgery Practice. In Movement Disorder Surgery; The Essentials. (Bakay R ed) Thieme Pub in press.

  9. Rosenow JM, Boongird A, Boulis NM , Rezai A. Surgical procedure for STN Stimulation. In Brain Stimulation and Epilepsy (Luders H ed),Chap 26, 323-327.

  10. Baker KB, Boulis NM , Montgomery EB, Rezai A. Target selection using microelectrode recordings. Microelectrode Recording in Movement Disorder Surgery. ( Israel and Burchiel eds), Thieme , New York ; pp138-151, 2004.

  11. McGillicuddy JE and Boulis NM . Techniques of Nerve Repair. in Neurosurgery, 3rd ed. (Wilkins and Rengenchary eds), in press.

  12. Singleton JR, Smith AG, Russell JW, Feldman EL. Polyneuropathy with impaired glucose tolerance (prediabetes): Implications for diagnosis and therapy. In: Current Treatment Options in Neurology, Current Science Inc., 2004.

  13. Russell JW, Kaminsky A. Oxidative injury in diabetic neuropathy. In: Nutrition and Diabetes: Pathophysiology and Management, Opara E, ed., CRC Press LLC, 2004.

  14. Russell JW, Sheikh Kiran, Reading P. Chronic autonomic neuropathies. In: Neurology Medlink, The Information Resource for Clinical Neurology, Gilman S, ed., Arbor Publishing, 2004.

  15. Russell JW. Bell’s palsy. In: Neurology Medlink, The Information Resource for Clinical Neurology, Gilman S, ed., Arbor Publishing, 2004.

  16. Reading P, Russell JW. Chronic autonomic neuropathies. In: Neurology Medlink, The Information Resource for Clinical Neurology, Gilman S, ed., Arbor Publishing, 2004.

  17. Russell JW, Reading P. Acute autonomic neuropathies. In: Neurology Medlink, The Information Resource for Clinical Neurology, Gilman S, ed., Arbor Publishing, 2004.

  18. Cowell RM and Russell JW. Peripheral Neuropathy and the Schwann Cell. In: Neuroglia, 2nd Edition, Kettenmann H, Ransom BR, eds., Oxford University Press, 573-585, 2004.

  19. Figlewicz, D.A., Barrett K., Haefele-Leskovar A., Forrester J.R., Sowden J.E., and Tawil R. FSHD myoblasts: in vitro studies. In FSHD Facioscapulohumeral Muscular Dystrophy. Ed. M. Upadahyaya and D.N. Cooper; chapter 16, p. 235-251 (2004).

  20. Leinninger GM, Feldman EL. Insulin-like growth factors in the treatment of neurological disease. In: Endocrine Development, Cianfarani S, Clemmons DR, Savage MO, eds., vol. 9, S. Karger AG, pp. 135-159, 2005.

  21. Feldman EL, Stevens MJ, Russell JW, Peltier A. Somatosensory neuropathy. In: The Diabetes Mellitus Manual, Inzucchi S, Porte Jr D, Sherwin RS, Baron A, eds., 6 th ed., McGraw-Hill, pp. 366-384, 2005.

  22. Vinik AI, Erbas T, Pfeifer MA, Feldman EL, Stevens MJ, Russell JW. Diabetic autonomic neuropathy. In: The Diabetes Mellitus Manual, Inzucchi S, Porte Jr D, Sherwin RS, Baron A, eds., 6 th ed., McGraw-Hill, pp. 347-365, 2005.

  23. Meyer G, Bole A, Feldman EL. Insulin-like growth factors and nervous system disorders. In: IGF and Nutrition in Health and Disease, Houston MS, Holly JMP, Feldman EL, eds., Humana Press, pp. 211-225, 2004.

  24. Sullivan KA, Feldman EL. Diabetic nerve disease, neuropathy. In: Encyclopedia of Endocrine Diseases, Martini L, ed., Elsevier, Inc., pp. 677-679, 2004.

  25. Feldman EL. Amyotrophic lateral sclerosis and other motor neuron diseases. In: Cecil Textbook of Medicine, Goldman L and Ausiello D, eds., 22 nd ed., W.B. Saunders, pp. 2316-2319, 2004.

  26. Feldman EL. Hereditary cerebellar ataxias and spastic paraplegias. In: Cecil Textbook of Medicine, Goldman L and Ausiello D, eds., 22 nd ed., W.B. Saunders, pp. 2314-2316, 2004.

Abstracts

  1. Corey JM, Gertz CC, Wang B-S, Birrell LK, Johnson SL, Mycek KB, Chen Q, Martin DC, Feldman EL, 2007.  Aligned Electrospun Nanofibers for Nervous System Regeneration.  J Peripher Nerv Syst 2007;12(S1):22.  Biannual Meeting of the Peripheral Nerve Society, Salt Lake City.

  2. Corey JM, Gertz CC, Wang B-S, Birrell LK, Johnson SL, Feldman EL, and Martin DC, 2007.  Motor Neurons Survival and Differentiation on Aligned PLLA Nanofibers: A Novel Substrate Design. Program No. P3.116. Abstract Viewer and Itinerary Planner on CD-ROM.  2007 Annual Fall Meeting of the Biomedical Engineering Society, Los Angeles.

  3. Abidian M, Richardson-Burns SM, Corey JM, Turer D, Martin DC, Kipke DR, 2007.  Bioactive Conducting Polymer Nanotubes for Neurite Outgrowth in Nerve Regeneration Applications. Program No. 936. Abstract Viewer and Itinerary Planner on CD-ROM.  2007 Annual Fall Meeting of the Biomedical Engineering Society. Los Angeles.

  4. Corey JM, Gertz CC, Wang B-S, Birrell LK, Johnson SL, Feldman EL, Martin DC, 2007. Electrospinning PLLA nanofibers directly on wet-PLGA-coated substrates facilitates serum-free culture of primary motor and sensory neurons. Program No. 872.28. Abstract Viewer and Itinerary Planner Online. Society for Neuroscience, San Diego.

  5. Gertz CC, Corey JM, Birrell LK, Wang B-S, Martin DC, Feldman EL, 2007. Nanofiber alignment accelerates differentiation of primary motoneurons in vitro. Program No. 872.29. Abstract Viewer and Itinerary Planner Online. Society for Neuroscience, San Diego.

  6. Hyperglycemia-Induced oxidative stress and Neuronal Injury. Sadidi M, Backus C., Lentz SI , Hayes JM, Feldman EL. Peripheral Nerve Society (PNS), International meeting, Snowbird UTAH, July 14-18, 2007.

  7. Post-translational Modification and Regulation of Bax by H2O2 in Neuroblastoma cells. Mahdieh Sadidi1*, Stephen I. Lentz2, and Eva L. Feldman1. HUPO 5th Annual World Congress October 28 - November 1, 2006, Long Beach, California.

  8. Bax regulation by Hydrogen Peroxide in Neuroblastoma Cells. Mahdieh Sadidi1*, Stephen I. Lentz2, and Eva L. Feldman1. ANA (American Neurological Association), October 8-11, 2006; Chicago, Illinois.

  9. Hydrogen peroxide-induced upregulation of the survival pathway in neuroblastoma cells. Sadidi M, Lentz SI, Hayes JM, Sullivan KA, Feldman EL. The Endocrine Society’s 88th Annual meeting, June (24-27) 2006, Boston, MA .

  10. AD Schuyler, HA Carlson and EL Feldman. Normal Mode Directed Exploration of Conformation Space as a Tool for Studying Macromolecular Interactions. Biophysical Society. 2008.

  11. AD Schuyler and EL Feldman. Iterative Cluster Normal Mode Analysis (icNMA): A Tool for Traversing the Conformation Energy Landscape with an Application to ALS. Biophysical Society. 2007.

  12. Sakowski SA, Lunn JS, Kim B, Feldman EL (2007) Motor neuron protection by vascular endothelial growth factor. Peripheral Nerve Society. Journal of the Peripheral Nervous System. 12(Suppl):74.
    * Sakowski SA, Lunn JS, Feldman EL (2007) Motor neuron protection by VEGF: Implications for Amyotrophic Lateral Sclerosis. ANA Abstract #M-46.

  13. Boulis NM, Garrity-Moses M., Qingshan T. Development of anti-apoptotic gene transfer as a means for neuroprotection against excitotoxicity. American Association of Neurological Surgeons.

  14. Boulis NM, Yang, J, Teng Q, Garrity-Moses M, Tanase D. RabG.EIAV-IGF-I peripheral injection prolongs survival in a mouse ALS model through retrograde gene delivery. American Association of Neurological Surgeons.

  15. Teng Q, Liu JK, Tanase D, Garrity-Moses ME, Boulis NM. AAVTET-ONLC: A Means For Controlled Synaptic Inhibition. Society for Neuroscience Abstract 12.4.

  16. Boulis NM, Garrity-Moses ME, Liu JK, Tanase D, Tang Q. EIAV-IGF-I Gene Transfer to Motor Neurons Enhances Motor Neuron Survival and Axonal Length. Society for Neuroscience Abstract 134.5.

  17. Garrity-Moses ME, Teng Q, Liu JK, Tanase D, Rezai A, Boulis NM. Adenoviral XIAP Expression Protects Motor Neurons In An In Vitro Model of Amyotrophic Lateral Sclerosis. Society for Neuroscience Abstract 312.10.

  18. Tanase D, Teng Q, Liu JK, Garrity-Moses ME, Boulis NM Reversible Neuromuscular Inhibition Through Transient Spinal Cord Tetanus Light Chain Gene Expression. Society for Neuroscience Abstract 874.6.

  19. Liu, JK, Tanase, D, Garrity-Moses, M, Teng, Q, Boulis NM Neuronal Binding of a Novel 12 AA Peptide Defined by Phase Display. Society for Neuroscience Abstract 876.9.

  20. Pilitsis, JG, Rezai A, Boulis NM, Henderson JM, Busch RM, Kubu CS. Postoperative confusion following STN DBS predicts greater neuropsychological difficulties in the longterm: Preliminary Findings. (2005) American Association of Neurological Surgeons.

  21. Krishnaney A, Zhao Z, Teng Q, Liu J, Garrity-Moses M, Davis M, Boulis NM. Adenoviral Light Chain Gene Expression in the Brainstem Induces Specific Motor Inhibition. Mol Therapy 9(Supp1): S19.

  22. Teng Q, Garrity-Moses M, Liu J, Tanase D, Mazarakis N, Azzouz M, Walmsely L, Boulis NM. EIAV-IGF-I Gene Transfer to Motor Neurons Enhances Axonal Length in Vitro. Mol Therapy 9(Supp1): S280.

  23. Tanase D, Garrity-Moses ME, Liu JK, Teng Q, Mazarakis N, Walmsely L, Azzouz M, Boulis NM. Cervical spinal cord delivery of a lentiviral vector in SOD-1 transgenic mice. Mol Therapy 9(Supp1): S201.

  24. Liu J, Teng Q, Tanase D, Garrity-Moses ME, Boulis NM. Neuronal membrane specific binding peptides isolated via phage display biopanning against trisialogangliosides. . Mol Therapy 9(Supp1): S167.

  25. Boulis NM, Teng Q, Liu J, Tanase D, Garrity-Moses M. Neurosurgical Gene-based Alternative to Deep Brain Stimulation and Botulinum Toxin. (2004) Abstracts of the American Association of Neurological Surgeons.

  26. Lentz SI, Leinninger GM, Backus C, Beals JL, Feldman EL. Glucose-mediated changes in mitochondrial dynamics associated with diabetic neuropathy. Endocrine Society Abstract, submitted.

  27. Vincent AM, Sullivan KA, Backus C, Feldman EL. RAGE activation injures primary sensory neurons via oxidative stress. Endocrine Society Abstract, submitted.

  28. Sadidi M, Lentz SI, Hayes JM, Sullivan KA, Feldman EL. Hydrogen peroxide-induced upregulation of the survival pathway in neuroblastoma cells. Endocrine Society Abstract, submitted.

  29. Perrone L, Backus C, Hayes JM, Feldman EL. Linking between rage endocytic trafficking. Endocrine Society Abstract, submitted.

  30. Kim B, Feldman EL. Dephosphorylation of tau by IGF-I is mediated by IGF-IR and IRS. Endocrine Society Abstract, submitted.

  31. Kim B, Schwab TS, Feldman EL. IRS-2 is the main signaling molecule for the anti-apoptotic effects of IGF-I in human neuroblastoma cells. Endocrine Society Abstract, submitted.

  32. Sullivan KA, Russell JW, Vincent AM, Hayes JM, Feldman EL. Superoxide dismutase 2 and diabetic neuropathy. Endocrine Society Abstract, submitted.

  33. Corey JM, Lin DY, Martin DC, Feldman EL. Electrospun nanofibers confer directional contact guidance to regenerating neurons. Annals of Neurology, 58 (Suppl 9), S65, 2005.

  34. Singleton JR, Russell JW, Feldman EL, Goldstein J, Bixby B, Smith AG. Diet and exercise is associated with sustained improvement in neuropathic pain in patients with prediabetes. Annals of Neurology, 58 (Suppl 9), S39, 2005.

  35. Kato K, Vincent AM, Backus C, Feldman EL. A novel antioxidant, resveratrol, prevents high glucose-induced apoptosis via NQO1 induction. Annals of Neurology, 58 (Suppl 9), S38, 2005.

  36. Kim B, Feldman EL. Insulin-like growth factor I induces preferential degradation of IRS-2 through the PI 3-kinase pathway in human neuroblastoma cells. Annals of Neurology, 58 (Suppl 9), S34, 2005.

  37. Russell JW, Peltier A, Goldstein J, Smith AG, Feldman EL, Singleton JR. Autonomic dysfunction and impaired glucose tolerance. Annals of Neurology, 58 (Suppl 9), S29, 2005.

  38. Vincent AM, Sullivan KA, Backus C, Feldman EL. RAGE activation injures primary sensory neurons via oxidative stress. Annals of Neurology, 58 (Suppl 9), S13, 2005.

  39. Leinninger GM, Backus C, Sastry AM, Yi Y-B, Wang C-W, Feldman EL. IGF-I inhibits high glucose-induced mitochondrial dysfunction in DRG neurons via Bim, Bax and the fission protein Drp1. Annals of Neurology, 58 (Suppl 9), S13, 2005.

  40. van Golen CM, Schwab TS, Soules M, Oh SS, Fung K, van Golen KL, Feldman EL. IGF-IR involvement in human neuroblastoma bone metastasis. Annals of Neurology, 58 (Suppl 9), S4, 2005.

  41. Smith SB, Smith AG, Russell J, Peltier A, Feldman EL, Goldstein J, Singleton JR. A practical lifestyle intervention for patients with prediabetes and polyneuropathy. Diabetes, 54, 900-P, 2005.

  42. Kato K, Vincent AM, Backus C, Feldman EL. Up-regulation of antioxidant enzyme, catalase, by high glucose via Nrf2/Keap1-dependent mechanisms in rat dorsal root ganglion. Diabetes, 54, 2304-PO, 2005.

  43. Smith S, Smith AG, Bixby BA, Hamwi J, Feldman EL, Russell JW, Peltier A, Goldstein J, Singleton JR. The efficacy of a practical diet and exercise counseling regimen on metabolic parameters and neuropathy progression in patients with impaired glucose tolerance and neuropathy. Neurology, 64, P06.124, 2005.

  44. Bixby BA, Singleton JR, Smith S, Hamwi J, Feldman EL, Russell JW, Peltier A, Goldstein J, Smith AG. The Utah Early Neuropathy Scale is a sensitive measure of early neuropathy associated with impaired glucose tolerance. Neurology, 64, P06.121, 2005.

  45. Vincent AM, Backus C, McLean LL, Feldman EL. In vitro drug screening for the prevention and treatment of diabetic neuropathy. Journal of the Peripheral Nervous System, 10 (Suppl 1), 101, 2005.

  46. Sullivan KA, Vincent AM, Schin ML, Backus C, Hayes JM, McLean LL, Burke K, Russell JW, Brosius F, Feldman EL. Characterization of new mouse models of diabetic neuropathy. Journal of the Peripheral Nervous System, 10 (Suppl 1), 91, 2005.

  47. Smith AG, Bixby B, Smith S, Howard J, Russell JW, Peltier AC, Goldstein J, Feldman EL, Katz B, Singleton JR. The effect of diet and exercise on neuropathy progression in subjects with impaired glucose tolerance. Journal of the Peripheral Nervous System, 10 (Suppl 1), 88, 2005.

  48. Russell JW, Peltier A, Sheikh K, Howard J, Goldstein J, Smith AG, Feldman EL, Singleton JR. Autonomic dysfunction in subjects with impaired glucose tolerance. Journal of the Peripheral Nervous System, 10 (Suppl 1), 78-79, 2005.

  49. Leinninger GM, Backus C, Sastry AM, Yi Y-B, Wang C-W, Feldman EL. IGF-I inhibits high glucose-induced mitochondrial dysfunction in DRG neurons via Bim, Bax and the fission protein Drp1. Journal of the Peripheral Nervous System, 10 (Suppl 1), 52, 2005.

  50. Leinninger GM, Backus C, Sastry AM, Yi Y-B, Wang C-W, Feldman EL. IGF-I protects mitochondria in DRG neurons from high glucose induced dysfunction via Bim, Bax and the fission protein Drp1. Endocrine Society Abstracts, P3-690, 715, 2005.

  51. van Golen CM, Schwab TS, Soules M, Oh SS, Fung K, van Golen KL, Feldman EL. The IGF-IR regulates bone metastasis in human neuroblastoma. Endocrine Society Abstracts, P2-679, 528, 2005.

  52. Kim B, Feldman EL. Insulin-like growth factor I induces preferential degradation of IRS-2 through the PI 3-kinase pathway in human neuroblastoma cells. Endocrine Society Abstracts, P2-134, 388-389, 2005.

  53. Vincent AM, Backus C, McLean LL, Feldman EL. In vitro screening of antioxidant dietary supplements for the prevention and treatment of diabetic neuropathy. Endocrine Society Abstracts, P2-5, 357-358, 2005.

  54. Sullivan KA, Vincent AM, Schin ML, Backus C, Hayes JM, McLean LL, Burke K, Russell JW, Brosius F, Feldman EL. Phenotypic characterization of new mouse models of diabetic complications. Endocrine Society Abstracts, P2-4, 357, 2005.

  55. Corey JM, Lin DS, Martin DC, Feldman EL. Aligned nanofibers support neuronal growth and directionally guide neurites. Annals of Neurology, 56 (8), S72, 2004.

  56. Leinninger GM, Backus C, Uhler MD, Lentz SI, Feldman EL. IGF-I protects hyperglycemic neurons from apoptosis via Akt activation and caspase inhibition. Annals of Neurology, 56 (8), S66-S67, 2004.

  57. Kim B, Oh SS, van Golen CM, Feldman EL. Differential regulation of insulin receptor substrate-1 degradation during apoptosis. Annals of Neurology, 56 (8), S66, 2004.

  58. Schwab TS, van Golen CM, Fung K, van Golen KL, Feldman EL. The IGF system regulates osteoprotegerin in human neuroblastoma cells. Annals of Neurology, 56 (8), S64, 2004.

  59. Smith AG, Howard JR, Feldman EL, Peltier A, Russell J, Goldstein J, Singleton R. Impaired glucose tolerance causes neuropathy (IGTN) study: baseline characteristics and first-year follow-up. Annals of Neurology, 56 (8), S62, 2004.
  60. Peltier AC, Singleton JR, Howard JR, Goldstein J, Smith AG, Feldman EL, Russell JW. Reproducibility of quantitative sensory testing in the clinical trial setting. Annals of Neurology, 56 (8), S60, 2004.

  61. Figlewicz D.A., Mobley B., Hong Y. GluR2 AMPA receptor subunit editing in spinal motor neurons. 15 th annual Symposium on ALS/MND. December 2004.

  62. Figlewicz D.A., Hong Y., Coltas I. Withdrawal from the cell cycle in FSHD myoblasts. 54 th annual meeting of the American Society for Human Genetics, October 2004.

  63. Figlewicz, D.A., Coltas, I. , Hong Y. Myogenesis in Facioscapulohumeral Dystrophy (FSHD) and Control Myoblasts. New Directions in Biology and Disease of Skeletal Muscle, San Diego, January 2004.

Books

  1. Houston MS , Holly JMP, Feldman EL. IGF and Nutrition in Health and Disease, Humana Press, Totowa, New Jersey, 2004.

  2. Atlas of Neuromuscular Diseases . A Practical Guideline. Feldman EL, Grisold W, Russell, JW, Zifro U, eds., Springer Wien New York, 2004.

  3. Feldman EL, Grisold W, Russell JW, Zifko UA. Atlas of Neuromuscular Diseases, Springer-Verlag/Wien, Austria, 2005.

Journals

To search for journals and those with links to full text web sites, go to PubMed Web site